Related references
Note: Only part of the references are listed.Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma
He-Yuan Hsieh et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2018)
Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma
Hongmin Chen et al.
MEDICAL SCIENCE MONITOR (2018)
Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer
Chao-Yueh Fan et al.
SCIENTIFIC REPORTS (2018)
Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
Wei Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma
Chia-Lun Chang et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
Yuxia Deng et al.
ONCOTARGET (2017)
Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
Hyun Ju Kim et al.
CANCER RESEARCH AND TREATMENT (2017)
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
Mohan Suntharalingam et al.
JAMA ONCOLOGY (2017)
Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries
Hongmei Zeng et al.
THORACIC CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012
Jeffrey V. Brower et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
Minghuan Li et al.
RADIATION ONCOLOGY (2016)
Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis
Chih-Yi Chen et al.
RADIOTHERAPY AND ONCOLOGY (2016)
High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis
Tao Song et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by 18FDG-PET/CT for esophageal cancer
Wen Yu et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer
Yang-Gun Suh et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Liru He et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients
Ted C. Ling et al.
CANCERS (2014)
Definitive chemoradiotherapy for esophageal cancer: 66 Gy versus 50 Gy, a retrospective study
J. -B. Clavier et al.
CANCER RADIOTHERAPIE (2013)
Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
Daniel King Hung Tong et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Share Paper
